Brief report: updated efficacy and safety data from an integrated analysis of entrectinib in locally advanced/metastatic ROS1 fusion-positive non-small-cell lung cancer
Fan, Y. Drilon, A. Chiu, C. H. Loong, H. H. F. Siena, S. Krzakowski, M. Dziadziuszko, R. Zeuner, H. Xue, C. Krebs, Matthew G
Fan, Y.
Drilon, A.
Chiu, C. H.
Loong, H. H. F.
Siena, S.
Krzakowski, M.
Dziadziuszko, R.
Zeuner, H.
Xue, C.
Krebs, Matthew G
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Case Report
Citation
Fan Y, Drilon A, Chiu CH, Loong HHF, Siena S, Krzakowski M, et al. Brief Report: Updated Efficacy and Safety Data From an Integrated Analysis of Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. Clinical lung cancer. 2023 Dec 7. PubMed PMID: 38245456. Epub 2024/01/21.